Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on EPS earning $1.54 per share. The company achieved an EPS of $1.75 per share in Q3 2021. Merck market research report covers key aspects about the firm, including company profile, financial highlights and key recent developments. The report is meant as a resource for investors to form a 360 degree understanding about the firm.
Table of Contents
- Overview
- Financial Highlights
- Outlook
- SWOT Analysis
- Business Segment Analysis
- Sales by Geographic Region
- Key Developments
- Excerpts from Earnings Conference Call
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,